There are no announcements yet.
Post-Traumatic Stress Disorder (commonly referred to by its acronym, PTSD) is a severe anxiety disorder that can develop after exposure to any event which results in psychological trauma. This event may involve the threat of death to oneself or to someone else, or to one's own or someone else's physical, sexual, or psychological integrity, overwhelming the individual's psychological defenses.
PTSD is a less frequent and more enduring consequence of psychological trauma than the more frequently seen acute stress response. PTSD has also been recognized in the past as railway spine, stress syndrome, shell shock, battle fatigue, traumatic war neurosis, or post-traumatic stress syndrome.
Diagnostic symptoms include re-experiencing original trauma(s), by means of flashbacks or nightmares; avoidance of stimuli associated with the trauma; and increased arousal, such as difficulty falling or staying asleep, anger, and hyper vigilance. Formal diagnostic criteria (both DSM-IV and ICD-9) require that the symptoms last more than one month and cause significant impairment in social, occupational, or other important areas of functioning (e.g. problems with work and/or relationships).
A study conducted at the Universitá di Firenze in Italy finds there is positive indications cannabis could help treat PTSD: "Consolidation refers to item stabilization in long-term memory. Retrieval renders a consolidated memory sensitive, and a "reconsolidation" process has been hypothesized to keep the original memory persistent. Some authors could not detect this phenomenon. Here we show that retrieved contextual fear memory is vulnerable to amnesic treatments and that the amygdala is critically involved. Cholinergic and histaminergic systems seem to modulate only consolidation, whereas cannabinoids are involved in both consolidation and reactivation. The liability of retrieved memory affords opportunities to treat disorders such as phobias, post-traumatic stress, or chronic pain, and these results help searching for appropriate therapeutic targets."
Raymond C. Dabney Raymond C. Dabney This is exactly why I wrote this statement.
We will probably put out the July 1, 2020 Edition after the Fourth...Raymond C. Dabney Raymond C. Dabney This is exactly why I wrote this statement.
We will probably put out the July 1, 2020 Edition after the Fourth of July, depending how today goes.
Our shares are not being issued tomorrow, at this point, I think we will have a VIRTUAL VIDEO PARTY on that Day.
Things have changed dramatically, everywhere, our PROJECTS have Grown immensely, at this point my Best Guess is September 1, 2020; "All Our" shares will be issued and still on TARGET for June 1, 2021 initial filings for Share Trading options.
*** There is so much work to be done, Step by Step.
*** AND we are beta launching our technology right now, so it has been EXTRA.
This is exactly why I wrote this statement.
I think in Life we are supposed to Accept the Things we can Not Change, and Change the Things we Can.
This is MUCH better than hammering your Soft Head against a NEGATIVE BRICK wall. We have had nothing but, Acceptance and Change.
Sometime you need to CHANGE your Path unexpectedly to find your way Around that BRICK wall.
And Then, we still Succeed, no matter what, no matter how long. Period.
If I could CHANGE a lot of things I would.
Oh yes, as I have said a few time now; There is some Good Change coming right around the corner
Raymond Show less
2 days ago
Raymond C. Dabney Raymond C. Dabney Going to need to open the doors and let everyone in the website soon. Been saying that for a minute and been waiting to get this work out of the way. As we can see just by opening the doors causes Great Work. Good thing EVERYONE can read EVERYTHING without being logged in.
Here we go! This is when the fun starts, we will be PUSHING HARD to Surpass 1 Million Members, TV/Media and some good Surprises will help that out.
We are certainly "Bringing it ALL Together".
2 days ago
Like2EditRemove Show more